Navigation Links
U.S. FDA Approves New Oral Contraceptive That Also Raises Folate Levels
Date:9/24/2010

ype="disc">
  • To prevent pregnancy
  • To treat premenstrual dysphoric disorder (PMDD) in women who choose the Pill for birth control
  • To treat moderate acne in women at least 14 years of age who choose to use the Pill for birth control and have started having menstrual periods
  • To provide folate supplementation in women who choose the Pill for birth control

  • Who Should Not Take Beyaz?

    Do not use Beyaz if you smoke and are over age 35. Smoking increases your risk of serious side effects from the Pill, which can be life-threatening, including blood clots, stroke, or heart attack. This risk increases with age and number of cigarettes smoked.

    Do not use Beyaz if you have kidney, liver, or adrenal disease, or if you have or have had blood clots, certain cancers, history of heart attack or stroke, or if you are or may be pregnant.

    What are the Most Serious Risks of taking Beyaz?

    Beyaz increases the risk of serious conditions including blood clots, stroke, and heart attack.  Risk of these conditions is highest during the first year of use.

    In addition, Beyaz contains drospirenone, a different kind of hormone that for some may increase potassium too much. Consult your healthcare provider if you are on daily long-term treatment for a chronic condition with medications that may also increase potassium (see below), as you should have a blood test to check your potassium level during the first month of taking Beyaz.

    What Medications May Increase Potassium?

    NSAIDs – ibuprofen (Motrin®, Advil®), naproxen (Aleve® and others) when taken long-term and daily for arthritis or other problems, potassium-sparing diuretics (spironolactone and others), potassium supplementation, ACE inhibitors (Capoten®, Vasotec®, Zestril®, and others), angiotensin-II receptor antagonists (Cozaar®, Diovan®
    '/>"/>

    SOURCE Bayer HealthCare Pharmaceuticals Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. FDA Approves NDA That Includes Psychiatric Data Collected by Centralized Raters
    2. FDA Approves New Dosing for FASLODEX® (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
    3. FDA Approves Pediatric Use of Chemical Poisoning Treatment
    4. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
    5. FDA Approves Vaccines for the 2010-2011 Influenza Season
    6. FDA Approves Strativa Pharmaceuticals Zuplenz® (ondansetron) Oral Soluble Film
    7. FDA Approves Sagent Pharmaceuticals Heparin Sodium Injection, USP
    8. U.S. FDA Approves Improved Performance of Riverain Medicals OnGuard Chest X-ray Computer-Aided Detection Technology
    9. FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women
    10. FDA Approves New Treatment for Late-Onset Pompe Disease
    11. FDA Approves Cefepime for Use In B. Brauns DUPLEX(R) System
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... BOULDER, Colo. , Nov. 25, 2014 ... ARRY ) today announced that its Chief ... speak at the following upcoming conferences.  The ... conferences through webcasts on the Array BioPharma ... ConferenceDate:Wednesday, December 3, 2014Time:1:30 p.m.  Eastern Time ...
    (Date:11/26/2014)... 25, 2014 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, ... Dr. Helen Torley , President and Chief Executive ... will be webcast through the "Investors" section of Halozyme,s corporate ... made available for 90 days following the event. To access ...
    (Date:11/24/2014)... Juno Therapeutics today announced that the ... company,s JCAR015 chimeric antigen receptor product candidate.  The ... refractory B-cell acute lymphoblastic leukemia and was filed ... Center, where Phase 1 clinical trials are currently ... important news for patients who may benefit from ...
    Breaking Medicine Technology:Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3
    (Date:11/26/2014)... (PRWEB) November 26, 2014 Anthropologists ... effectiveness in containing and stopping Ebola, improve international ... in healthcare systems in West Africa. , ... to Stop Ebola: Anthropologists Offer Insights,” will be ... the American Anthropological Association (AAA), Fri., Dec. 5, ...
    (Date:11/26/2014)... San Luis Obispo, CA (PRWEB) November 26, 2014 ... bunion treatment, is offering lower prices in an early ... November 26th, Bunion Booties are being offered at the ... Black Friday promotional pricing is in addition to any ... Bootie, visit the Bunion Bootie website for ...
    (Date:11/26/2014)... News Facts , Lexmark’s ... RSNA 2014 in Chicago. The company will demonstrate ... images, photos, videos and documents found throughout the ... learn more about these innovative medical content management ... initiatives – that enable more informed clinical decisions, ...
    (Date:11/26/2014)... who enter puberty early are at increased risk for ... linked with a number of factors associated with depression, ... to the researchers. Early puberty was also linked to ... and having friends who were prone to getting into ... an association between early puberty and these factors, it,s ...
    (Date:11/26/2014)... The number of emergency department visits in the United States ... 136 million in 2011, according to the U.S. Centers for ... fewer people were going to ERs with non-urgent medical needs: ... within two hours of arriving at the ER. In 2010, ... Sixty percent of patients arrived at the ER after normal ...
    Breaking Medicine News(10 mins):Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:ER Visits on the Rise, Study Reports 2
    ... Neurological Disease have now proved using a specialized mouse ... produced by neurons.// The results of this study have ... the two. ,Also known as apoE, this ... apoE4, is the major known genetic risk factor for ...
    ... Foundation has found that more than 60 percent of people ... food debris// struck in between their teeth. Items like screwdrivers, ... survey said. ,More disturbingly, the survey said that ... rise to oral health problems and bad breath. "Clearly people ...
    ... is running short of faculty members and its current strength ... ,Replying to a question, minister of state for health ... running with just 479 faculty members as against its sanctioned ... that during 2003-05, 20 faculty members had either resigned or ...
    ... and Medicaid Services in Baltimore and George Washington University ... who are depressed resort to nursing homes. Depression among ... of the patient. Hence the researchers analyzed the relationship ... surveyed a total of 141,000 seniors. About 13261 of ...
    ... Although the new government health refoms have cost millions of pounds ... very little benefit for the patients//. ,Cosultants pay and pension ... state that there is no difference to patient care. ... the hospitals. There has been no planning and no guidance on ...
    ... but still South Africa's own nursing community is faced ... salute the nurses of South Africa and celebrate those ... lives of others in need," said Siphokazi Phillip, international ... Africa (Denosa). ,According to Philip although there ...
    Cached Medicine News:Health News:Alzheimer's-linked apolipoprotein E produced by neurons, Gladstone study 2Health News:Nurses in South Africa Face Challenges 2
    Intended for the quantitative determination of gammaglutamyl transferase activity in serum or plasma. Single vial, dry powder reagent. Readily soluble at room temperature. Reaction: Kinetic. Waveleng...
    Intended for the quantitative determination of calcium in serum. Endpoint Reaction. Reaction complete within one minute, color developed is stable for 30 minutes. Wavelength: 570 nm. Linearity: 16 mg...
    For the quantitative determination of alanine aminotransferase in serum used in routine examination and monitoring of therapy and relapses....
    For the quantitative determination of Alanine Aminotransferase in serum. Optimized IFCC without P-5'-P, Linearity: 500 IU/L at 37 C. Liquid Working Reagent prepared with simple 1:9 dilution....
    Medicine Products: